Entrada Therapeutics

Entrada Therapeutics

Aims to treat devastating diseases through the intracellular delivery of biologics.

HQ location
Boston, United States
Launch date
Employees
Market cap
$216m
Enterprise value
($83m)
Share price
$5.65 TRDA
Authorizing premium user...